Skip to main content
. 2021 Sep 4;41(10):853–863. doi: 10.1007/s40261-021-01060-3
Medicare patients with antipsychotic dose reductions may have increased health care resource use and be at increased risk for mental health-related clinical outcomes.
Antipsychotic dose reductions may increase overall health care burden for some patients with schizophrenia.